Condition: Febrile Neutropenia · Sponsor: Boris Böll
The aim of this prospective, observational, non-interventional, multi-centre study of the diagnostic use of DISQVER in neutropenic patients with FN is to provide further evidence of the efficacy of an NGS-based approach for detecting bloodstream infection in neutropenic patients.
This description comes directly from the study's public registry record.
Boris Böll · +4922147842579 · boris.boell@uk-koeln.de
Jorge Garcia Borrega · +4922147842579 · jorge.garcia-borrega@uk-koeln.de
Always discuss trial participation with your own doctor first.
| University Hospital of Cologne | Cologne, Germany | Recruiting |
| Hospital Dessau | Dessau, Germany | Recruiting |
| University Hospital of Essen | Essen, Germany | Recruiting |
| University Hospital of Frankfurt | Frankfurt am Main, Germany | Recruiting |
| University Hospital of Leipzig | Leipzig, Germany | Recruiting |
| University Hospital of Magdeburg | Magdeburg, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05815628